Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
【発明の名称】N-(4-ヒドロキシフェニル)レチンアミド-O-グルクロニドのC-グリコシド類似物
Document Type and Number:
Japanese Patent JPH09509680
Kind Code:
A
Abstract:
The present invention provides breast cancer chemopreventive arylamide analogues of retinoic acid, more particularly C-glycoside analogues of N-(4-hydroxyphenyl)retinamide-O-glucuronide and N-glycoside analogue of retinoyl beta -glucuronide that resist both beta -glucuronidase mediated enzymatic hydrolysis as well as acid catalyzed hydrolysis. Specifically, the drugs include 4-(retinamido)phenyl-C-glucuronide; 4-(retinamido)phenyl-C-glucoside; 4-(retinamido)benzyl-C-xyloside; 4-(retinamido)benzyl-C-glucoside; 4-(retinamido)benzyl-C-glucuronide; 4-(retinamido)phenyl-C-xyloside, 1-(B-D-glucopyranosyl)retinamide and 1-(D-glucopyranosyluronosyl)retinamide. The invention also relates to a method for making such drugs.

Inventors:
Curly, Robert WJ
Robage, Michael Jay
Application Number:
JP51115696A
Publication Date:
September 30, 1997
Filing Date:
September 26, 1995
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
The Ohio State Research Foundation
International Classes:
C07H5/06; A61K31/70; A61K31/7008; A61K31/7024; A61P35/00; C07H13/02; C07H13/04; C07H13/06; (IPC1-7): C07H13/02; A61K31/70; C07H5/06
Attorney, Agent or Firm:
Yuzo Yamazaki (1 person outside)